Gene · 4048
Papers1,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 1,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| OpenCell: Endogenous tagging for the cartography of human cellular organization. | Science | 2022 | 35271311 | PubTator, text mining | PubMed |
| Histone deacetylase inhibitors inhibit cervical cancer growth through Parkin acetylation-mediated mitophagy. | Acta Pharm Sin B | 2022 | 35256949 | PubTator, text mining | PubMed |
| Utilizing Bioinformatics Technology to Explore the Potential Mechanism of Danggui Buxue Decoction against NSCLC. | Dis Markers | 2022 | 35256890 | PubTator, text mining | PubMed |
| Emerging Biomarkers Beyond Leukotrienes for the Management of Nonsteroidal Anti-inflammatory Drug (NSAID)-Exacerbated Respiratory Disease. | Allergy Asthma Immunol Res | 2022 | 35255534 | PubTator, text mining | PubMed |
| Dysregulated Immunity in Pulmonary Hypertension: From Companion to Composer. | Front Physiol | 2022 | 35250621 | PubTator, text mining | PubMed |
| An inhibitor of leukotriene-A4 hydrolase from bat salivary glands facilitates virus infection. | Proc Natl Acad Sci U S A | 2022 | 35238649 | PubTator, text mining | PubMed |
E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition. | Semin Immunol | 2022 | 35227568 | PubTator, text mining | PubMed |
| Glomerular Biomechanical Stress and Lipid Mediators during Cellular Changes Leading to Chronic Kidney Disease. | Biomedicines | 2022 | 35203616 | PubTator, text mining | PubMed |
| An update of label-free protein target identification methods for natural active products. | Theranostics | 2022 | 35198076 | PubTator, text mining | PubMed |
| Shifting the Biosynthesis of Leukotrienes Toward Specialized Pro-Resolving Mediators by the 5-Lipoxygenase-Activating Protein (FLAP) Antagonist BRP-201. | J Inflamm Res | 2022 | 35173459 | PubTator, text mining | PubMed |
| NSAIDs and Cancer Resolution: New Paradigms beyond Cyclooxygenase. | Int J Mol Sci | 2022 | 35163356 | PubTator, text mining | PubMed |
| Revisiting miRNA Association with Melanoma Recurrence and Metastasis from a Machine Learning Point of View. | Int J Mol Sci | 2022 | 35163222 | PubTator, text mining | PubMed |
| A New Prospect for the Treatment of Nephrotic Syndrome Based on Network Pharmacology Analysis. | Curr Res Physiol | 2022 | 35098155 | PubTator, text mining | PubMed |
| Function-guided proximity mapping unveils electrophilic-metabolite sensing by proteins not present in their canonical locales. | Proc Natl Acad Sci U S A | 2022 | 35082156 | PubTator, text mining | PubMed |
| Gold micro-particles for knee osteoarthritis. | Eur J Pain | 2022 | 35076138 | PubTator, text mining | PubMed |
| The Compound (E)-2-Cyano-N,3-diphenylacrylamide (JMPR-01): A Potential Drug for Treatment of Inflammatory Diseases. | Pharmaceutics | 2022 | 35057082 | PubTator, text mining | PubMed |
| Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation. | J Biol Chem | 2022 | 35032548 | PubTator, text mining | PubMed |
| Elevation of activated neutrophils in chronic rhinosinusitis with nasal polyps. | J Allergy Clin Immunol | 2022 | 34953792 | PubTator, text mining | PubMed |
| Fragment-to-Lead Medicinal Chemistry Publications in 2020. | J Med Chem | 2022 | 34928151 | PubTator, text mining | PubMed |
| An immunodominant NP105-113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease. | Nat Immunol | 2022 | 34853448 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4048/papers?page=15